European Metals Holdings Limited

Regulatory Filings • Jan 30, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4069B

European Metals Holdings Limited

30 January 2020

For immediate release

30 JANUARY 2020

EUROPEAN METALS HOLDINGS LIMITED

CANCELLATION OF SECURITIES 

European Metals Holdings Limited ("European Metals" or "the Company") advises that a total of 1,400,000 ordinary shares (represented by Chess Depositary Interests or "CDIs") have been forfeited by previous executive members of the Company following their resignations.  The CDIs that were issued to the previous executive members under the Employee Securities Incentive Plan ("Plan") was announced on 6 June 2018. 

Total voting rights

Following the cancellation of securities, the Company will have 151,703,973 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights in the Company are therefore 151,703,973 and shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

ENQUIRIES:

European Metals Holdings Limited Keith Coughlan, Managing Director Julia Beckett, Company Secretary	Tel: +61 (0) 419 996 333 Email: [email protected] Tel: +61 (0) 8 6245 2050 Email: [email protected]
Beaumont Cornish (Nomad & Broker) Michael Cornish Roland Cornish	Tel: +44 (0) 20 7628 3396 Email: [email protected]

The information contained within this announcement is considered to be inside information, for the purposes of Article 7 of EU Regulation 596/2014, prior to its release. 

The person who authorised for the release of this announcement on behalf of the Company was Keith Coughlan, Managing Director.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NAVFZGFMVGFGGZG